EKF Diagnostics Investor Announcements

EKF Diagnostics Holdings plc is an in-vitro diagnostics (IVD) business. The Company is engaged in the designing, development, manufacture and selling of diagnostic analyzers, reagents and ancillary products. This activity takes place across several geographical locations which include the United Kingdom, United States of America, Germany, Poland and Russia.

Pages:

15

Director / PDMR Shareholding

12^th Jul 2016

Directorate Change

11^th Jul 2016

EKF Diagnostics announces the appointment of Carl Dominic Contadini, an Operational Adviser to Harwood Capital LLP, as Non-Executive Director with immediate effect.

6^th Jul 2016

EKF Diagnostics Holdings plc provides the following update on trading for the six months ended 30 June 2016.

Director / PDMR Shareholding

27^th Jun 2016

Director / PDMR Shareholding

24^th Jun 2016

Director / PDMR Shareholding

22^nd Jun 2016

TR-1 notification of major interest in shares

22^nd Jun 2016

Director/PDMR Shareholding

21^st Jun 2016

Director Dealings

10^th Jun 2016

TR-1 notification of major interest in shares

9^th Jun 2016

Pages:

15

Archive

EKF Diagnostics

EKF Diagnostics Holdings plc is a manufacturer and distrbutor of IVD products. It has three core divisions: Point of Care including hemoglobin and HbA1c analyzers; Central Laboratory including the manufacture of enzymes and clinical chemistry; and Molecular Diagnostics which incorporates a unique DNA enrichment technology, PointMan, and a portfolio of molecular testing services.

News & events

Texas WIC Nutrition & Breastfeeding Conference 2017

WIC’s annual conference, the Texas WIC Nutrition & Breastfeeding Conference promotes best practices in the field and provides continuing education. Among the nearly 600 WIC community members who attend the conference, are representatives from the WIC state agency, as well as administrators and staff from local WIC agencies and clinics across Texas.

EKF at Africa Health 2017

Africa Health Exhibition is the continent’s largest healthcare exhibition and is a leading platform for the industry to meet, learn and do business.

EKF at EuroMedLab 2017

Meet with EKF Sales Managers at the 22nd IFCC – EKLM European Congress of Clinical Chemistry and Laboratory Medicine.

Who has the highest risk of developing anemia?

What is anemia and which groups of people have the highest risk of developing the disorder? How can hemoglobin testing help with identification and patient management?

EKF expands geographical reach of PCT test for early sepsis detection

EKF brings niche Stanbio Chemistry Procalcitonin LiquiColor^® assay to new markets.

Product showcase

Copyright © 2021 | Powered by Intergage

Quick links

News and Events

Anemia and Hemoglobin testing

Diabetes and HbA1c testing

Support

Social media

ekf orange

Please note: Not all products are available in all countries. Please check availability.

Privacy | Terms & Conditions | Terms of Sale | UK Modern Slavery Act